Utah Medical Products Stock Analysis
UTMD Stock | USD 69.47 0.08 0.12% |
Utah Medical Products is fairly valued with Real Value of 69.85 and Hype Value of 69.39. The main objective of Utah Medical stock analysis is to determine its intrinsic value, which is an estimate of what Utah Medical Products is worth, separate from its market price. There are two main types of Utah Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Utah Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Utah Medical's stock to identify patterns and trends that may indicate its future price movements.
The Utah Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Utah Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Utah Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Utah Medical's ongoing operational relationships across important fundamental and technical indicators.
Utah |
Utah Stock Analysis Notes
About 72.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.92. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 14th of March 2024. The entity had 3:2 split on the 22nd of March 1993. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. For more information please call Kevin Cornwell at 801 566 1200 or visit https://www.utahmed.com.Utah Medical Quarterly Total Revenue |
|
Utah Medical Products Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Utah Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Utah Medical Products or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Utah Medical generated a negative expected return over the last 90 days | |
About 72.0% of the company outstanding shares are owned by institutional investors | |
On 3rd of April 2024 Utah Medical paid $ 0.3 per share dividend to its current shareholders | |
Latest headline from news.google.com: Utah Medical Q1 Earnings Snapshot - Barchart |
Utah Medical Products Upcoming and Recent Events
Earnings reports are used by Utah Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Utah Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
23rd of April 2024 Upcoming Quarterly Report | View | |
31st of March 2024 Next Fiscal Quarter End | View |
Utah Largest EPS Surprises
Earnings surprises can significantly impact Utah Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1995-07-17 | 1995-06-30 | 0.19 | 0.21 | 0.02 | 10 | ||
1994-01-28 | 1993-12-31 | 0.16 | 0.14 | -0.02 | 12 | ||
1993-07-14 | 1993-06-30 | 0.17 | 0.15 | -0.02 | 11 |
Utah Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical Products backward and forwards among themselves. Utah Medical's institutional investor refers to the entity that pools money to purchase Utah Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Jpmorgan Chase & Co | 2023-12-31 | 63.6 K | Penn Mutual Asset Management Llc | 2023-12-31 | 53.1 K | Loomis, Sayles & Company Lp | 2023-12-31 | 44.4 K | Franklin Resources Inc | 2023-12-31 | 43.3 K | Northern Trust Corp | 2023-12-31 | 38.6 K | Bank Of New York Mellon Corp | 2023-12-31 | 36.5 K | Brandes Investment Partners & Co | 2023-12-31 | 32.8 K | Clean Yield Group Inc | 31.7 K | Isthmus Partners Llc | 2023-12-31 | 22.7 K | Fmr Inc | 2023-12-31 | 389.7 K | T. Rowe Price Investment Management,inc. | 2023-12-31 | 269.2 K |
Utah Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 249.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Utah Medical's market, we take the total number of its shares issued and multiply it by Utah Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Utah Profitablity
Utah Medical's profitability indicators refer to fundamental financial ratios that showcase Utah Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Utah Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Utah Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Utah Medical's profitability requires more research than a typical breakdown of Utah Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.33 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.34 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.34. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.14 | 0.28 | |
Return On Capital Employed | 0.14 | 0.13 | |
Return On Assets | 0.12 | 0.21 | |
Return On Equity | 0.13 | 0.12 |
Management Efficiency
Utah Medical Products has return on total asset (ROA) of 0.0849 % which means that it generated a profit of $0.0849 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1333 %, meaning that it created $0.1333 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Utah Medical's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Utah Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 0.95, whereas Non Currrent Assets Other are projected to grow to (0.95).Last Reported | Projected for Next Year | ||
Book Value Per Share | 35.36 | 37.13 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 30.22 | 31.73 | |
Enterprise Value Over EBITDA | 8.59 | 11.31 | |
Price Book Value Ratio | 2.38 | 4.37 | |
Enterprise Value Multiple | 8.59 | 11.31 | |
Price Fair Value | 2.38 | 4.37 | |
Enterprise Value | 177.7 M | 92.5 M |
The analysis of Utah Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Utah Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Utah Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0172 | Forward Dividend Yield 0.0172 | Forward Dividend Rate 1.2 | Beta 0.13 |
Technical Drivers
As of the 8th of May, Utah Medical has the Risk Adjusted Performance of (0.06), variance of 2.21, and Coefficient Of Variation of (883.59). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have collected data for thirteen technical drivers for Utah Medical Products, which can be compared to its competition. Please validate Utah Medical Products mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 69.47 per share. Given that Utah Medical Products has information ratio of (0.16), we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.Utah Medical Products Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Utah Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Utah Medical Products. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Utah Medical Products Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Utah Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Barbara Payne over two weeks ago Disposition of 1097 shares by Barbara Payne of Utah Medical at 93.7911 subject to Rule 16b-3 | ||
Brian Koopman over a month ago Disposition of 366 shares by Brian Koopman of Utah Medical at 101.88 subject to Rule 16b-3 | ||
Kevin Cornwell over a month ago Disposition of 2401 shares by Kevin Cornwell of Utah Medical at 91.759 subject to Rule 16b-3 | ||
Brian Koopman over three months ago Acquisition by Brian Koopman of 500 shares of Utah Medical subject to Rule 16b-3 | ||
Brian Koopman over six months ago Bona fide gift to Brian Koopman of tradable shares of Utah Medical subject to Section 16 | ||
Paul Richins over six months ago Sale by Paul Richins of 700 shares of Utah Medical | ||
Paul Richins over a year ago Bona fide gift to Paul Richins of 150 shares of Utah Medical subject to Section 16 |
Utah Medical Predictive Daily Indicators
Utah Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Utah Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Utah Medical Corporate Filings
8K | 6th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 25th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
15th of April 2024 Other Reports | ViewVerify | |
10th of April 2024 Other Reports | ViewVerify | |
10K | 26th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 9th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Utah Medical Forecast Models
Utah Medical's time-series forecasting models are one of many Utah Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Utah Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Utah Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Utah Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Utah shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Utah Medical. By using and applying Utah Stock analysis, traders can create a robust methodology for identifying Utah entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.40 | 0.27 | |
Operating Profit Margin | 0.37 | 0.25 | |
Net Profit Margin | 0.33 | 0.20 | |
Gross Profit Margin | 0.48 | 0.44 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Utah Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Utah Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 1.19 | Earnings Share 4.5 | Revenue Per Share 13.531 | Quarterly Revenue Growth (0.09) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.